Moneycontrol PRO

business

Prefer Sun Pharma, Lupin on correction: Ambareesh Baliga

Ambareesh Baliga, Independent Market Expert is of the view that one may prefer Sun Pharma and Lupin on correction.

first published: Dec 14, 2015 04:59 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347